Cargando…
Blood MCP-1 levels are increased in chronic obstructive pulmonary disease patients with prevalent emphysema
BACKGROUND AND AIMS: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease characterized by different phenotypes with either bronchial airways alterations or emphysema prevailing. As blood biomarkers could be clinically useful for COPD stratification, we aimed at investigating the...
Autores principales: | Di Stefano, Antonino, Coccini, Teresa, Roda, Elisa, Signorini, Cinzia, Balbi, Bruno, Brunetti, Giuseppe, Ceriana, Piero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973466/ https://www.ncbi.nlm.nih.gov/pubmed/29872287 http://dx.doi.org/10.2147/COPD.S159915 |
Ejemplares similares
-
How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn
por: Signorini, Cinzia, et al.
Publicado: (2021) -
Safety Evaluation of Engineered Nanomaterials for Health Risk Assessment: An Experimental Tiered Testing Approach Using Pristine and Functionalized Carbon Nanotubes
por: Coccini, Teresa, et al.
Publicado: (2013) -
MCP-4 and Eotaxin-3 Are Novel Biomarkers for Chronic Obstructive Pulmonary Disease
por: Fang, Chun, et al.
Publicado: (2023) -
Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease
por: Fujimoto, Keisaku, et al.
Publicado: (2011) -
Standard spirometry to assess emphysema in patients with chronic obstructive pulmonary disease: the Emphysema Severity Index (ESI)
por: Dal Negro, Roberto W., et al.
Publicado: (2021)